-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Veracyte, Maintains $48 Price Target

Benzinga·04/01/2026 11:42:29
Listen to the news
Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and maintains $48 price target.